INSIGHTS ON DRUG DEVELOPMENT

• Calcium Carbonate Vs Titanium Dioxide: Why Particle Engineering Matter

  Discover how particle-engineered calcium carbonate offers a viable alternative to titanium dioxide in tablet coatings, achieving good opacity, process efficiency, and comparable tablet properties.

• Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation Development

  Explore a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input.

• Lentiviral Vector Upstream Process

  Scalable lentiviral vector production is moving beyond adherent systems. Learn how streamlined workflows enable linear scale-up in stirred-tank bioreactors for cost-effective gene therapy manufacturing.

• How AI And Automation Are Impacting Process Development

  David Ford, Senior Director of Chemistry at Snapdragon Chemistry, on the mountain of data behind every process development program — and why AI's real promise is surfacing the right piece of it at the moment a team needs to decide.

• API In Capsule Vs. The Lost Art Of Formulation Development

  11/5/2025

  API-in-capsule offers a fast path for early clinical data, but it can't eliminate the need for full formulation development. Weighing the potential for higher total development time and cost is critical.

• Modifying The Micro-Environment To Improve Dissolution Rate

  6/11/2025

  Discover how modifying the micro-environment with targeted excipients can significantly enhance the dissolution rate of poorly soluble drugs using conventional manufacturing methods.

• Nitrosamine Testing: How To Ensure Regulatory Compliance, Product Safety

  9/16/2025

  Explore what nitrosamines are, why testing matters, and how we're able to deliver high-confidence solutions through advanced science and industry-leading expertise.

• 5 Trends Impacting CMOs In 2025

  2/4/2025

  In 2025, CMOs will navigate Annex 1 compliance, the BioSecure Act’s uncertainty, AI-driven drug development, supply chain challenges from tariffs, and pandemic preparedness strategies.

• Optimizing Yield, Purity, And Scalability In A Cost-Effective Manner During Process Development

  7/23/2026

  Daniele Vigo, Assistant Director at Cambrex Milan, on getting yield, purity, and scalability right without burning through the budget.